The impact of alcohol and illicit drugs on people with psychosis: The second Australian national survey of psychosis

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 9, 2012, Pages 864-878

  Moore, Elizabeth ^a   Mancuso, Serafino G ^b   Slade, Tim ^c   Galletly, Cherrie ^d,e,f   Castle, David J ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b St Vincent's Melbourne   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e Ramsay Health Care   (Australia)

^f Northern Sector   (Australia)

Author keywords

Alcohol abuse dependence; Australia; cannabis abuse dependence; psychosis

Indexed keywords

CANNABIS; ILLICIT DRUG; STREET DRUG;

ADULT; AGE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ALCOHOLISM; ARTICLE; AUSTRALIA; BODY MASS; CANNABIS ADDICTION; DISEASE ASSOCIATION; DISEASE DURATION; DRUG ABUSE; EDUCATIONAL STATUS; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PREVALENCE; PSYCHOSIS; SEX DIFFERENCE; ADOLESCENT; COMORBIDITY; DRINKING BEHAVIOR; DRUG USE; HEALTH SURVEY; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; ALCOHOL DRINKING; ALCOHOLISM; AUSTRALIA; BODY MASS INDEX; COMORBIDITY; DRUG USERS; FEMALE; HALLUCINATIONS; HEALTH SURVEYS; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; STREET DRUGS;

EID: 84873202822     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412443900     Document Type: Article

References (33)

1. National Survey of Mental Health and Wellbeing: Summary of Results. Canberra: Australian Bureau of Statistics ; 2008
2. 2010 National Drug Strategy Household Survey Report. Drug Statistics Series No. 25. Canberra: Australian Institute of Health and Welfare ; 2011
3. Babor TF, Higgins-Biddle JC, Saunders JB, et al AUDIT, the Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. 2001 ) AUDIT, the Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care, 2nd edition.Geneva: World Health Organization, Department of Mental Health and Substance Dependence. Geneva: World Health Organization, Department of Mental Health and Substance Dependence ; 2001
4. Blanchard JJ, Brown SA, Horan WP, et al. Substance use disorders in schizophrenia: review, integration, and a proposed model. Clinical Psychology Review. 2000 ; 20: 207-234
5. Castle DJ, Jablensky A, McGrath JJ, et al. The diagnostic interview for psychoses (DIP): development, reliability and applications. Psychological Medicine. 2006 ; 36: 69-80
6. Cooper J, Mancuso SG, Borland R, et al. Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosis. Australian and New Zealand Journal of Psychiatry. 2012 ;: 851-863
7. Darke S. Self-report among injecting drug users: a review. Drug and Alcohol Dependence. 1998 ; 51: 253-263
8. Drake RE, Mueser KT, Brunette MF. Management of persons with co-occuring severe mental illness and substance use disorder: program implications. World Psychiatry. 2007 ; 6: 131-136
9. Elvevåg B, Goldberg TE. Cognitive impairment in schizophrenia is the core of the disorder. Critical Reviews in Neurobiology. 2000 ; 14: 1-21
10. Fowler IL, Carr VJ, Carter NT, et al. Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin. 1998 ; 24: 443-455
11. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction (to Alcohol and Other Drugs). 1991 ; 86: 1119-1127
12. Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry. 2000 ; 34: 221-236
13. Kavanagh DJ, Waghorn G, Jenner L, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research. 2004 ; 66: 115-124
14. Kirkpatrick B, Amador XF, Flaum M, et al. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse. Schizophrenia Research. 1996 ; 20: 69-77
15. Koskinen J, Löhönen J, Koponen H, et al. Prevalence of alcohol use disorders in schizophrenia - a systematic review and meta-analysis. Acta Psychiatrica Scandinavica. 2009 ; 120: 85-96
16. Koskinen J, Löhönen J, Koponen H, et al. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: A meta-analysis. Schizophrenia Bulletin. 2010 ; 36: 1115-1130
17. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. American Journal of Psychiatry. 1974 ; 131: 1121-1123
18. Morgan VA, Waterreus A, Jablensky A, et al. People living with psychotic illness in 2010. The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry. 2012 ;: 735-752
19. Mueser KT, Drake RE, Wallach MA. Dual diagnosis: A review of etiological theories. Addictive Behaviors. 1998 ; 23: 717-734
20. Mueser KT, Noordsy DL, Drake RE, et al Integrated Treatment for Dual Disorders. New York: The Guilford Press ; 2003
21. Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophrenia Bulletin. 1990 ; 16: 31-56
22. O'Daly OG, Guillin O, Tsapakis E-M, et al. Schizophrenia and substance abuse co-morbidity: A role for dopamine sensitization?. Journal of Dual Diagnosis. 2005 ; 1: 11-40
23. Potvin S, Joyal CC, Pelletier J, et al. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis. Schizophrenia Research. 2008 ; 100: 242-251
24. Potvin S, Sepehry AA, Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychological Medicine. 2006 ; 36: 431-440
25. Potvin S, Sepehry AA, Stip E. Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Australian and New Zealand Journal of Psychiatry. 2007 ; 41: 792-799
26. Rabin RA, Zakzanis KK, George TP. The effects of cannabis use on neurocognition in schizophrenia: a meta analysis. Schizophrenia Research. 2011 ; 128: 111-116
27. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA: the Journal of the American Medical Association. 1990 ; 264: 2511-2518
28. Salyers MP, Mueser KT. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophrenia Research. 2001 ; 48: 109-123
29. An Access Economics Report for SANE Australia. Melbourne, Australia: SANE ; 2002
30. Skinner HA. The drug abuse screening test. Addictive Behaviors. 1982 ; 7: 363-371
31. Spencer C, Castle D, Michie PT. Motivations that maintain substance use among individuals with psychotic disorders. Schizophrenia Bulletin. 2002 ; 28: 233-247
32. Talamo A, Centorrino F, Tondo L, et al. Comorbid substance-use in schizophrenia: Relation to positive and negative symptoms. Schizophrenia Research. 2006 ; 86: 251-255
33. Thornton LK, Baker AL, Johnson MP, et al. Perceptions of anti-smoking public health campaigns among people with psychotic disorders. Mental Health and Substance Use. 2011 ; 4: 110-115